Baxter Healthcare S. A.
|Baxter Healthcare S. A. Patent applications|
|Patent application number||Title||Published|
|20130043383||Methods of Determining Polydispersity and/or Molecular Weight Distribution of a Polyethylene Glycol Sample - Disclosed herein are methods of determining polydispersity (PDI) and molecular mass distribution (MMD) of reactive PEG samples using mass spectrometry. More specifically, a mass spectrometry method called GEMMA is used to determine PDI and MMD of PEG samples which provides more accurate measurements for high molecular weight PEG samples than prior known MALDI-TOF analysis.||02-21-2013|
|20090239821||DESTRUCTION OF MICROBIAL PRODUCTS BY ENZYMATIC DIGESTION - Methods of treating a dialysis component by providing a dialysis component and contacting the dialysis component with an enzyme are provided. The enzyme breaks down microbial contaminants in the dialysis component. The enzyme may be separated from the dialysis component to provide a purified dialysis component. The purified dialysis component may be substantially free of microbial contaminants that cause a cytokine response in humans.||09-24-2009|
Patent applications by Baxter Healthcare S. A.